Home
Conditions
Leukemia, B-Cell

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,388 public trials 159 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00138164

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Completed

Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00058396

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

BCX-1777 in Treating Patients With Refractory Cancer

NCT00073944

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +140 more
Locations: Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT00873457

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)

NCT00593944

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Roswell Park Cancer Institute Buffalo, New York, United States

Oncology Consultants, PA Houston, Texas, United States

View Trial Details

Completed

SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial

NCT00898872

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +42 more
Locations: Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States

Piedmont Hospital Atlanta, Georgia, United States

Northside Hospital Cancer Center Atlanta, Georgia, United States

Saint Joseph's Hospital of Atlanta Atlanta, Georgia, United States

View all 82 locations

View Trial Details

Completed

Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction

NCT00054483

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blood Protein Disorders, +74 more
Locations: University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

NCT01144260

Conditions: B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +14 more
Locations: City of Hope National Medical Center Duarte, California, United States

UT M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis

NCT00001586

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00060255

Conditions: Amyloidosis, Blast Crisis, Blood Protein Disorders, +84 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Leukemia, B-Cell

Leukemia, B-Cell trial results

Related conditions